Novocure (NVCR) Tops Q1 EPS by 14c

Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.04), $0.14 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $137.5 million versus the consensus estimate of $134.08 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Goldman "broadly" raises estimates for LTL and truckload stocks